Pictet Asset Management SA grew its position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 222.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,183 shares of the biotechnology company’s stock after buying an additional 17,384 shares during the quarter. Pictet Asset Management SA’s holdings in Axon Enterprise were worth $5,662,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. ICA Group Wealth Management LLC acquired a new position in Axon Enterprise during the 4th quarter worth approximately $25,000. U.S. Capital Wealth Advisors LLC acquired a new position in Axon Enterprise during the 4th quarter worth approximately $29,000. Spire Wealth Management acquired a new position in Axon Enterprise during the 1st quarter worth approximately $31,000. Roble Belko & Company Inc acquired a new position in Axon Enterprise during the 4th quarter worth approximately $33,000. Finally, EverSource Wealth Advisors LLC acquired a new position in Axon Enterprise during the 4th quarter worth approximately $42,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Stock Up 0.7 %
Axon Enterprise stock opened at $200.30 on Thursday. The company has a quick ratio of 2.98, a current ratio of 3.38 and a debt-to-equity ratio of 0.47. The firm’s fifty day moving average is $192.43 and its 200 day moving average is $203.56. Axon Enterprise, Inc. has a 12-month low of $109.31 and a 12-month high of $229.95. The company has a market capitalization of $14.97 billion, a PE ratio of 149.48 and a beta of 0.88.
Analyst Ratings Changes
Get Our Latest Stock Report on AXON
Insider Activity
In other news, Director Julie A. Cullivan sold 1,180 shares of the stock in a transaction dated Tuesday, May 30th. The shares were sold at an average price of $196.00, for a total value of $231,280.00. Following the completion of the sale, the director now owns 5,882 shares in the company, valued at $1,152,872. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Axon Enterprise news, Director Julie A. Cullivan sold 1,180 shares of the stock in a transaction dated Tuesday, May 30th. The shares were sold at an average price of $196.00, for a total transaction of $231,280.00. Following the completion of the transaction, the director now owns 5,882 shares in the company, valued at $1,152,872. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Joshua Isner sold 1,482 shares of the stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $196.88, for a total transaction of $291,776.16. Following the transaction, the chief operating officer now owns 319,803 shares of the company’s stock, valued at approximately $62,962,814.64. The disclosure for this sale can be found here. Insiders sold a total of 52,445 shares of company stock worth $10,136,611 over the last quarter. Insiders own 6.10% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Bear Market vs Recession: What Are the Differences?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 7 Best AI Mutual Funds (and ETFs) to Sweep the AI Craze
- How to Choose Top Rated Stocks
- Auto Parts Stocks Shift Gears: Which is the Right One to Buy?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.